COMP <GO>
XPEV vs PG // RETURN ON INVESTED CAPITAL (ROIC)
XPeng Inc. American (NYSE) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: XPEV 3
— PG 12
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: PG
LAST: $9.04 (-1.53%) • MKT CAP: $8.80B
roic
9.90%
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
roic
25.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XPEV VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | XPEV | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 51.20% | -10.20 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 9.90% | 25.40% | -15.50 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.0x | 16.2x | +4.80 | PG | /valuation <GO> |
| Free Cash Flow Yield | 2.21% | 3.77% | -1.56 | PG | /fcf-yield <GO> |
| Operating Margin | 13.90% | 24.30% | -10.40 | PG | /operating-margins <GO> |
| Net Profit Margin | 10.90% | 19.00% | -8.10 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 6.60% | 0.30% | +6.30 | XPEV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.74 | 5.59 | -1.85 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | XPEV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 6.50% | +0.50 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.4 | 62.7 | -23.30 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.03 | 0.87 | +0.16 | XPEV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.5x | 21.7x | +8.80 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $8.80B | $372.21B | -$363.42B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | XPEV REV | PG REV | XPEV GROSS % | PG GROSS % | XPEV FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $84.28B | — | 51.2% | — | $14.04B |
| FY 2024 | — | $84.04B | — | 51.4% | — | $16.52B |
| FY 2023 | — | $82.01B | — | 44.0% | — | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XPEV // BETA 1.03
PG // BETA 0.87